CVS Health Survey Reports Increases in Mental Health Concerns Since 2020
Pharmacy Times
MAY 12, 2024
The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Pharmacy Times
MAY 12, 2024
The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.
Pharmacy Times
FEBRUARY 7, 2024
Investigators also found that the mortality rates for cardiovascular disease from 2020 to 2022 reversed the improvements of reduced mortalities in the preceding decades.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JULY 8, 2024
The portion of physicians surveyed by the American Medical Association (AMA) who report at least one symptom of burnout has dropped below 50%, a first since the onset of the COVID-19 pandemic. |
Drug Topics
MARCH 22, 2024
Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.
Pharmacy Times
SEPTEMBER 7, 2023
Black women had the highest rates of obesity-related cardiovascular disease deaths whereas other racial groups had more men experiencing obesity-related CVD deaths than women.
Fierce Healthcare
OCTOBER 25, 2023
States have accelerated legislation intended to promote health equity in the last few years, with a special focus on several key areas like bias training and maternal health,
Drug Topics
APRIL 27, 2023
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
Pharmacy Times
OCTOBER 13, 2023
Adolescents with mental health conditions must be monitored as they are at a higher demand for the need of mental health care.
Drug Topics
JANUARY 26, 2023
Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.
Pharmacy Times
AUGUST 24, 2022
Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.
Drug Topics
AUGUST 29, 2022
Using electronic medical record data from 2018-2020 obtained from 24 medical centers across the US, including Johns Hopkins, University of Colorado, and Mayo Clinic institutions, a new study suggests rates of youth onset type 2 diabetes increased 77% during the first year of the pandemic.
STAT
AUGUST 8, 2024
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday.
PhRMA
JANUARY 25, 2023
decrease between 2019 and 2020 alone, increasingly reflects advances in prevention and treatment—including new medicines which have improved survival across a range of cancers. million averted cancer deaths over this period. The report notes the continued decline in death rates since 1991, including a 1.5%
STAT
OCTOBER 14, 2024
health care system pivoted to meet Covid-19 in 2020, routine health visits and screenings where many cancer cases would have been caught didn’t happen. That leaves a troubling mystery for epidemiologists, as it means experts still don’t know what happened with the roughly 130,000 cancer cases that were missed in 2020.
Fierce Pharma
JUNE 29, 2023
After an initial rejection in 2020 and a review delay earlier this year, BioMarin’s Roctavian has finally got the FDA go-ahead to introduce a gene therapy for a not-so-rare disorder.
Fierce Healthcare
OCTOBER 10, 2023
LAS VEGAS — The team at retail giant Walmart didn't realize how fortuitous a virtual primary care pilot would prove to be when it launched in January of 2020. | LAS VEGAS — The team at retail giant Walmart didn't realize how fortuitous a virtual primary care pilot would prove to be when it launched in January of 2020.
Pharmacy Times
OCTOBER 4, 2024
Significant polarization surrounding COVID-19 vaccinations in late 2020 and early 2021 looked to have had an impact in increasing vaccine hesitancy.
STAT
JANUARY 12, 2023
Vaccinations among children remain high, but the trend — with coverage dropping from about 95% in the 2019-2020 school year to 94% in 2020-2021 to 93% in 2021-2022, according to the data released Thursday — has health officials concerned. The percentage of U.S.
Pharmacy Times
AUGUST 16, 2024
Craig Beavers discusses significance of the 2024 update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure.
Fierce Pharma
AUGUST 8, 2024
It was 2020 and Maryland biotech Novavax was thinking big. Novavax purchased the site in May of 2020 for $167 million with the intent of it producing more than 1 billion doses annually there. Novavax purchased the site in May of 2020 for $167 million with the intent of it producing more than 1 billion doses annually there.
STAT
MAY 1, 2024
When Maureen Amirault purchased her first electric wheelchair in 2020, she had been living with muscular dystrophy for decades. Braces and a cane helped, but walking became too arduous, so she got a chair through a company called Numotion. The first few months were great. The headrest fell off, but Numotion fixed it in a matter of days.
Fierce Pharma
SEPTEMBER 20, 2024
Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday. That changed Friday.
STAT
NOVEMBER 8, 2023
When Ken Song was getting ready to leave his job as the CEO of a small biotech in 2020, he wasn’t sure what was next. But he knew one thing. “I deliberately said I’m not going to do oncology. Oncology is so crowded. Everybody thinks they have the solution, but the reality is, it’s all noise,” he said.
Fierce Healthcare
JANUARY 11, 2024
Charges for electronic, asynchronous clinician-patient messaging — or e-visits — have persisted in the wake of an early-2020 spike during the COVID-19 pandemic. After an early 2020 spike, monthly claims for e-visits rose from 64,000 in June 2021 to 107,000 by Sept.
STAT
JUNE 19, 2024
Priscilla Agnew-Hines will never be able to forget that day in early 2020. On March 26, just weeks after Covid-19 officially became a global pandemic, her son died from an overdose. Larry, 41, was a chef, a drummer for his gospel church and the son who challenged Priscilla’s barbecue skills during summer cookouts.
Pharmacy Times
SEPTEMBER 14, 2023
Investigators found an approximately 23% decrease in overall cancer incidence in April 2020, specifically for breast, colon, rectal, head and neck cancers, as well as melanoma and endocrine cancer diagnoses.
Fierce Healthcare
OCTOBER 15, 2024
Telemedicine companies, including those that prescribe Adderall, will be able to continue prescribing as they have since 2020.
Pharmacy Times
FEBRUARY 2, 2024
Daratumumab and hyaluronidase-fihj in combination with other therapies was previously approved by the FDA in May 2020 for 8 indications in multiple myeloma.
STAT
OCTOBER 23, 2024
In August of 2020, a study published in the Proceedings of the National Academies of Science made headlines with its finding that Black infants were half as likely to survive to their first birthday when they were cared for by white doctors instead of Black ones.
PhRMA
NOVEMBER 17, 2022
As a result of Part D, nearly 90% of Medicare beneficiaries have comprehensive drug coverage, amounting to more than 47 million beneficiaries in 2020. Part D beneficiaries have a variety of plans to choose from, ranging from 24 to 32 options in each state. But open enrollment can be confusing.
Fierce Healthcare
JUNE 20, 2024
UnitedHealthcare unveiled the program in 2020. UnitedHealthcare is offering a look at the impacts its Level2 diabetes program is having on members. Level2 provides members with multiple connected devices they can use to manage Type 2 diabetes, including a continuous glucose monitor and activity tracker.
STAT
JULY 31, 2024
These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.
STAT
SEPTEMBER 14, 2023
Today, it is no longer a new public health enigma, but the outlook for sufferers is no better than when the condition was first recognized in early 2020. Hopes were raised in December 2020 when Congress provided $1.15 Long Covid goes by many names. Although its prevalence has recently decreased to 6% of the U.S.
STAT
AUGUST 28, 2024
Fatal drug overdoses shot up during the peak of Covid-19 in 2020. And as the dust settled on the pandemic, it quickly became clear that one demographic group had fared far worse than any other: Native Americans.
Pharmacy Times
OCTOBER 31, 2023
According to 2020 data from the CDC, about 14.5% of adults reported having trouble falling asleep most or every day during the 30 days prior to the survey.
Fierce Pharma
NOVEMBER 20, 2024
Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are already eying the blockbuster as a potential target. | The spinal muscular atrophy drug is a growth driver for the Swiss pharma giant, prompting the company to prioritize its defense against potential generics.
STAT
MAY 16, 2024
Started in 2020 , it’s an effort to boost the numbers of both Indigenous physicians and doctors willing to treat patients in rural areas experiencing severe physician shortages. Read the rest…
STAT
JUNE 27, 2024
Drinking, which was already on the rise before 2020, became a coping mechanism for overburdened parents, burnt-out workers, the traumatized, and the bored. In the pit of the pandemic, with no one to see and nowhere to go, and horrors unfolding daily outside the front door, there was for many a reliable bright spot: the 5 p.m.
STAT
APRIL 16, 2024
WASHINGTON — President Joe Biden’s administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the Covid-19 outbreak that suddenly halted normal life around the globe in 2020.
STAT
OCTOBER 15, 2024
It was a dramatic call to action by the American Heart Association: The organization declared its decade-long goal culminating in 2020 was to slash deaths from cardiovascular disease and stroke by 20%. It also promised in its scientific journal to move all Americans toward “ideal cardiovascular health.”
STAT
MARCH 28, 2024
While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary.
Fierce Pharma
MAY 28, 2024
Since NS Pharma launched its Duchenne muscular dystrophy (DMD) drug Viltepso (viltolarsen) in 2020, sales have steadily
Fierce Healthcare
OCTOBER 31, 2023
Healthcare startup Olive saw a meteoric rise in 2020 and 2021, spurred by the digital health funding boom and the need for automation during the COVID-19 pandemic. | It marks the end of the line for healthcare automation startup Olive AI.
STAT
MARCH 4, 2024
The Covid group was compared with an uninfected control group and a group of patients who had influenza during the same period from 2020 to 2022. AIRDs include rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, mixed connective tissue disease, vasculitis, and other conditions. Read the rest…
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content